U.S. Aerospace & Defense Stock News

NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

A Look At Astrana Health’s Valuation As Upcoming Earnings Test Optimistic Growth Expectations

Upcoming earnings put Astrana Health in focus Astrana Health (ASTH) is back on investors’ radar ahead of its March 2, 2026 quarterly earnings report, with attention on whether results and guidance align with the company’s recent revenue and earnings profile. See our latest analysis for Astrana Health. At a share price of US$20.33, Astrana Health has seen recent momentum soften, with a 30 day share price return of 10.6% decline and a 1 year total shareholder return of 19.9% loss, even as its...
NYSE:BBU
NYSE:BBUIndustrials

Brookfield Business Partners (NYSE:BBU) Valuation Check After Fresh Outperform Ratings From CIBC And BMO Capital

CIBC and BMO Capital have both highlighted Brookfield Business Partners (NYSE:BBU) with fresh Outperform ratings, drawing attention to its track record, ties to the broader Brookfield group, and current valuation. See our latest analysis for Brookfield Business Partners. At around US$34.08, Brookfield Business Partners has seen short term share price pressure, with a 1-day share price return of 1.70% decline and a year to date share price return of 4.88% decline. However, its 1-year total...
NYSE:URI
NYSE:URITrade Distributors

United Rentals Procore Telematics Link Aims To Deepen Customer Ties

United Rentals (NYSE:URI) and Procore Technologies launched a new telematics integration that brings rental equipment data directly into Procore's Resource Management solution. The collaboration connects jobsite equipment usage and location data with project planning tools to support more precise resource allocation. The integration is designed to help contractors address equipment inefficiencies and improve coordination across construction projects. For you as an investor, this move sits...
NYSE:CRH
NYSE:CRHBasic Materials

How Record 2025 Results And Higher Payouts At CRH (CRH) Have Changed Its Investment Story

In February 2026, CRH plc reported fourth‑quarter 2025 revenue of US$9,416 million and net income of US$1,025 million, delivering record full‑year 2025 results with revenue of US$37,447 million and net income of US$3,753 million, alongside a 5% increase in its quarterly dividend to US$0.39 per share and continued share buybacks. CRH also issued 2026 guidance for net income of US$3.90–US$4.10 billion and diluted EPS of US$5.60–US$6.05, which, together with sustained margin expansion, higher...
NYSE:DE
NYSE:DEMachinery

A Look At Deere (DE) Valuation As Guidance Lift And Bayer Partnership Renew Investor Interest

Deere (DE) is back in focus after raising its full-year 2026 earnings guidance, reporting first quarter results, and expanding its precision agriculture connectivity through a new Bayer partnership. See our latest analysis for Deere. The raised guidance, stronger first quarter sales and the new Bayer connectivity feature have arrived alongside a 34.9% year to date share price return and a 92.14% five year total shareholder return. This suggests momentum has recently strengthened after a...
NasdaqGS:CIFR
NasdaqGS:CIFRSoftware

Cipher Digital Pivot Tests New HPC Model And Hyperscaler Reliance

Cipher Digital, formerly focused on Bitcoin mining, has completed a full pivot to high performance computing infrastructure under the ticker NasdaqGS:CIFR. The company has rebranded, exited its legacy mining stakes, and repositioned itself as an operator of HPC data centers. Cipher Digital has secured long term data center agreements with major cloud providers including AWS, Fluidstack, and Google. The company has raised capital through bond offerings to support its shift toward hyperscale...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

Does Sharplink’s New Crypto Voice Reshape Its Ethereum Narrative for Investors in SBET?

Sharplink, Inc. recently appointed veteran cryptocurrency journalist Steven Ehrlich as Head of Research and Communications to strengthen its outreach to retail and institutional investors around the long term Ethereum opportunity. This hire brings a high-profile crypto media voice in-house, potentially sharpening how Sharplink explains and positions its large Ethereum treasury platform to the market. With Ehrlich’s communications experience now in place, we’ll explore how this leadership...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

A Look At Cytokinetics (CYTK) Valuation After Recent Share Price Pullback

Cytokinetics (CYTK) has been drawing investor attention after a period of mixed share performance, with a roughly 1.5% decline over the past month and about a 5.8% decline over the past 3 months. See our latest analysis for Cytokinetics. At a share price of US$62.22, Cytokinetics has given up some near term momentum with a 7 day share price return of negative 8.42%. However, its 1 year total shareholder return of 35.26% and 5 year total shareholder return of 216.16% show that longer term...
NYSE:UHS
NYSE:UHSHealthcare

Universal Health Services (UHS) Is Down 10.6% After Mixed 2025 Results And Strong 2026 Guidance - Has The Bull Case Changed?

Universal Health Services, Inc. recently reported its fourth-quarter and full-year 2025 results, with quarterly net revenues of US$4,486.05 million and net income of US$445.94 million, alongside full-year net revenues of US$17,364.83 million and net income of US$1,488.8 million. At the same time, management issued 2026 guidance calling for net revenues of about US$18.42–US$18.79 billion and diluted EPS of US$22.64–US$24.52, highlighting expectations for continued growth despite recent...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

A Look At JetBlue Airways (JBLU) Valuation After Wider Loss And Updated Capacity And Revenue Guidance

JetBlue Airways (JBLU) drew fresh investor attention after reporting a wider-than-expected fourth quarter loss and issuing guidance that highlights expected capacity growth, cost trends excluding fuel, and potential revenue per seat improvements. See our latest analysis for JetBlue Airways. JetBlue's latest quarter and guidance arrive after a choppy year, with a 90 day share price return of 23.94% and a 1 year total shareholder return of 15.03% decline. This suggests that short term momentum...
NYSE:GPC
NYSE:GPCRetail Distributors

Does GPC’s Dividend Hike and Business Split Plan Change The Bull Case For Genuine Parts?

In February 2026, Genuine Parts Company reported fourth-quarter and full-year 2025 results showing higher sales but a net loss in the quarter, issued 2026 guidance, raised its annual dividend to US$4.25 per share, outlined continued M&A spending of US$300 million to US$350 million, and advanced plans to separate its automotive and industrial businesses by early 2027. An interesting angle is that Genuine Parts is pairing a 70th consecutive year of dividend increases with a planned business...
NasdaqGS:EZPW
NasdaqGS:EZPWConsumer Finance

Is It Too Late To Consider EZCORP (EZPW) After Its 1 Year 92% Share Price Surge?

If you are wondering whether EZCORP is attractively priced after its recent run, this article will walk through how the current share price stacks up against several valuation checks. EZCORP last closed at US$26.53, with returns of 4.6% over the past 7 days, 23.7% over 30 days, 32.3% year to date and 92.8% over 1 year. The 3 year and 5 year returns sit at 192.8% and 410.2% respectively. Recent news coverage around EZCORP has focused on its role in the diversified financials space and...
NasdaqGS:NSSC
NasdaqGS:NSSCElectronic

Is It Too Late To Consider Napco Security Technologies (NSSC) After A 93% One Year Rally?

If you are wondering whether Napco Security Technologies' current share price reflects its true worth, you are not alone. Many investors are trying to work out if the recent run still leaves room for value. The stock closed at US$46.61, with returns of 1.6% over the last 7 days, 26.3% over 30 days, 12.6% year to date and 92.9% over 1 year. The 3 year and 5 year returns stand at 47.4% and 182.8% respectively. Recent news coverage has largely focused on Napco Security Technologies as a...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

A Look At American Superconductor (AMSC) Valuation After Its Strong Fiscal Q3 Earnings Surprise

American Superconductor (AMSC) is back in focus after reporting fiscal third quarter earnings per share of $2.81 on revenue that was 20% higher than a year earlier, far above prior expectations. See our latest analysis for American Superconductor. Despite the earnings surprise, American Superconductor’s share price has recently cooled, with a 1-day share price return of a 6% decline and a 7-day share price return of a 4% decline, following a 30-day share price return of 8.9% and a 1-year...
NYSE:AIZ
NYSE:AIZInsurance

Will Assurant’s (AIZ) Ninth Year of Profits and 2026 Buybacks Redefine Its Investment Narrative

In late February 2026, Assurant reported its fourth quarter and full-year 2025 results, marking a ninth consecutive year of profitable growth and announcing a US$250 million to US$350 million share repurchase range for 2026. Positive coverage from major firms, including reiterated Hold and Buy ratings, underscored how earnings resilience and capital return plans are shaping investor perceptions of Assurant’s business quality. Next, we’ll examine how Assurant’s sustained profitable growth and...
NYSE:LHX
NYSE:LHXAerospace & Defense

L3Harris Contracts And IPO Plan Reframe Long Term Defense Exposure

L3Harris Technologies (NYSE:LHX) secured its largest full rate production contract for submarine communications shipsets, tied to critical naval platforms. The company won a new contract to supply components for the THAAD missile defense system, reinforcing its role in U.S. missile defense infrastructure. L3Harris announced a major manufacturing expansion, with billions earmarked to increase solid rocket motor output across U.S. facilities. The company plans an IPO for its Missile Solutions...
NasdaqGS:INDV
NasdaqGS:INDVPharmaceuticals

Indivior Pharmaceuticals (INDV) Valuation Check After Strong Long Term Shareholder Returns

Why Indivior Pharmaceuticals (INDV) is on investors’ radar today Indivior Pharmaceuticals (INDV) focuses on treatments for opioid use disorder and overdose, and recent share performance may have prompted investors to reassess how its current valuation lines up with its fundamentals. See our latest analysis for Indivior Pharmaceuticals. At a share price of $32.72, Indivior Pharmaceuticals has seen recent share price pressure, with a 1 month share price return of 7.52% and a year to date share...
NasdaqGS:BL
NasdaqGS:BLSoftware

Is BlackLine (BL) Now Attractive After A Multi Year Share Price Slide

If you are wondering whether BlackLine is starting to look interesting at today’s price, this article will walk through what that current market value might be implying about the business. BlackLine’s share price recently closed at US$35.25, with returns of 2.5% decline over 7 days, 24.1% decline over 30 days, 34.5% decline year to date, 27.0% decline over 1 year, 50.0% decline over 3 years, and 68.4% decline over 5 years that may have reshaped how the market views its potential and...
NYSE:GM
NYSE:GMAuto

Does Iowa’s OnStar Data Lawsuit Reshape the Bull Case for General Motors’ Software Ambitions (GM)?

Iowa Attorney General Brenna Bird has sued General Motors and its OnStar unit, alleging they collected and sold detailed driving data from Iowans without consent since 2015, in violation of the Iowa Consumer Fraud Act. The case spotlights how GM’s push to monetize connected-vehicle data through services like OnStar can collide with evolving expectations around privacy and transparency. We’ll now examine how this alleged misuse of OnStar driving data could affect GM’s investment narrative...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

Is NovoCure (NVCR) Pricing Look Out Of Step With Recent Share Rebound

If you are looking at NovoCure and wondering whether the recent share price makes sense, this article will walk through what that price might be implying about the stock's value. The shares last closed at US$13.67, with returns of 20.3% over the past 7 days and 10.2% over 30 days, set against a 4.2% return year to date and a 28.3% decline over 1 year, and an 82.5% and 89.4% decline over 3 and 5 years respectively. Recent news coverage around NovoCure has focused on the company as a Nasdaq...
NasdaqGS:GTM
NasdaqGS:GTMInteractive Media and Services

Assessing ZoomInfo Technologies (GTM) Valuation After Nvidia CEO Support And AI Initiatives

ZoomInfo Technologies (GTM) moved back into focus after Nvidia CEO Jensen Huang argued that artificial intelligence is more likely to support, not threaten, enterprise software providers such as ZoomInfo. See our latest analysis for ZoomInfo Technologies. Even after reacting positively to Jensen Huang’s comments, ZoomInfo’s share price remains under pressure, with a 30 day share price return of 22.86% and a 1 year total shareholder return of 46.74%. This indicates that recent momentum has...
NYSE:AWI
NYSE:AWIBuilding

Why Armstrong World Industries (AWI) Is Down 12.8% After Soft 2026 Guidance Despite Record 2025 Results

In February 2026, Armstrong World Industries reported Q4 2025 results showing higher year-on-year sales and earnings, but both revenue and EPS came in below analyst expectations, and the company issued 2026 earnings guidance that was softer than the market had anticipated. At the same time, Armstrong outlined 2026 targets for net sales of US$1.75–US$1.79 billion and net earnings of US$340–US$349 million, giving investors clearer insight into how management sees demand, margins, and capital...
NYSE:CCL
NYSE:CCLHospitality

Carnival Corporation (CCL) Valuation Check After Carnival Millions Launch And Mexico Itinerary Changes

Carnival Corporation & (CCL) is back in focus after rolling out its fleetwide Carnival Millions digital lottery, while simultaneously rerouting ships away from Puerto Vallarta and canceling some Mexico excursions in response to cartel related violence. See our latest analysis for Carnival Corporation &. Recent news on Carnival Millions and route adjustments sits against a share price of US$31.55, with a 30 day share price return of 5.1% and a 90 day share price return of 21.7%. The 1 year...
NYSE:Q
NYSE:QSemiconductor

Is It Too Late To Consider Qnity Electronics (Q) After Its Rapid Share Price Rally

If you are wondering whether Qnity Electronics at around US$126.76 is still a fair deal or already priced for perfection, you are in the right place. The stock has been active recently, with returns of 11.7% over 7 days, 31.8% over 30 days and 49.2% year to date, which can change how the market is thinking about both its potential and its risks. Recent coverage of Qnity Electronics has focused on its position within the semiconductor space and how investors are reacting to its current...